Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-11

Clinical Trial Update: Autoimmune Dementia: Predictors of Neuronal Synaptic Antibodies in Patients With New-ONset Cognitive Impairment

View source ↗

Summary

A new clinical study is recruiting to identify predictors of neuronal synaptic antibodies in patients with new-onset cognitive impairment. The study focuses on …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Azienda Usl di Bologna | Conditions: Cognitive Impairment, Dementia | Status: RECRUITING